| Theophylline | Approved Investigational | PPP2CA | 5515 |
downregulated | Theophylline results in decreased expression of PPP2CA mRNA | 5q31.1 | |
| Theophylline | Approved Investigational | PPP3CB | 5532 |
downregulated | Theophylline results in decreased expression of PPP3CB mRNA | 10q22.2 | |
| Theophylline | Approved Investigational | PRKAA1 | 5562 |
downregulated | Theophylline results in decreased expression of PRKAA1 mRNA | 5p13.1 | |
| Theophylline | Approved Investigational | PRKCA | 5578 |
downregulated | Theophylline results in decreased expression of PRKCA mRNA | 17q24.2 | |
| Theophylline | Approved Investigational | PROSER3 | 148137 |
upregulated | Theophylline results in increased expression of PROSER3 mRNA | 19q13.12 | |
| Theophylline | Approved Investigational | PTP4A1 | 7803 |
downregulated | Theophylline results in decreased expression of PTP4A1 mRNA | 6q12 | |
| Theophylline | Approved Investigational | PTPN2 | 5771 |
upregulated | Theophylline results in increased expression of PTPN2 mRNA | 18p11.21 | |
| Theophylline | Approved Investigational | PTPRE | 5791 |
upregulated | Theophylline results in increased expression of PTPRE mRNA | 10q26.2 | |
| Theophylline | Approved Investigational | RAB11B | 9230 |
upregulated | Theophylline results in increased expression of RAB11B mRNA | 19p13.2 | |
| Theophylline | Approved Investigational | RAD9A | 5883 |
downregulated | Theophylline results in decreased expression of RAD9A mRNA | 11q13.2 | |
| Theophylline | Approved Investigational | RANGRF | 29098 |
upregulated | Theophylline results in increased expression of RANGRF mRNA | 17p13 | |
| Theophylline | Approved Investigational | RASAL2 | 9462 |
downregulated | Theophylline results in decreased expression of RASAL2 mRNA | 1q25.2 | |
| Theophylline | Approved Investigational | RCAN1 | 1827 |
upregulated | Theophylline results in increased expression of RCAN1 mRNA | 21q22.12 | |
| Theophylline | Approved Investigational | RDH10 | 157506 |
upregulated | Theophylline results in increased expression of RDH10 mRNA | 8q21.11 | |
| Theophylline | Approved Investigational | RGS16 | 6004 |
upregulated | Theophylline results in increased expression of RGS16 mRNA | 1q25.3 | |
| Theophylline | Approved Investigational | RIOK3 | 8780 |
downregulated | Theophylline results in decreased expression of RIOK3 mRNA | 18q11.2 | |
| Theophylline | Approved Investigational | RPS15 | 6209 |
downregulated | Theophylline results in decreased expression of RPS15 mRNA | 19p13.3 | |
| Theophylline | Approved Investigational | SBSPON | 157869 |
downregulated | Theophylline results in decreased expression of SBSPON mRNA | 8q21.11 | |
| Theophylline | Approved Investigational | SDS | 10993 |
upregulated | Theophylline results in increased expression of SDS mRNA | 12q24.13 | |
| Theophylline | Approved Investigational | SETD2 | 29072 |
downregulated | Theophylline results in decreased expression of SETD2 mRNA | 3p21.31 | |
| Theophylline | Approved Investigational | SIKE1 | 80143 |
upregulated | Theophylline results in increased expression of SIKE1 mRNA | 1p13.2 | |
| Theophylline | Approved Investigational | SLC39A9 | 55334 |
upregulated | Theophylline results in increased expression of SLC39A9 mRNA | 14q24.1 | |
| Theophylline | Approved Investigational | SMU1 | 55234 |
upregulated | Theophylline results in increased expression of SMU1 mRNA | 9p21.1 | |
| Theophylline | Approved Investigational | SNHG4 | 724102 |
upregulated | Theophylline results in increased expression of SNHG4 mRNA | 5q31.2 | |
| Theophylline | Approved Investigational | SPATS2L | 26010 |
downregulated | Theophylline results in decreased expression of SPATS2L mRNA | 2q33.1 | |